CDEK by Data4ThePeople
Sign in Sign up
← All organizations

BioXcel Therapeutics Inc

For profitWebsite ↗

Also known as: BIOXCEL | BioXcel Therapeutics | BioXcel Therapeutics Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 12, 2019

First marketed drug

Apr 5, 2022

Last known activity

Jun 19, 2025

Timeline

2010s

  1. Jun 1, 2017

    BioXcel Therapeutics Inc— Founded

2020s

  1. Apr 5, 2022

    dexmedetomidine— Marketing Organization

  2. Apr 5, 2022

    dexmedetomidine— NDA Secondary Org

Drugs by trial phase (4 distinct, 21 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (27)

Details

Founded
Branford, CT, US Jun 1, 2017
Last known activity
Jun 19, 2025